• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊癌症发热性中性粒细胞减少症患者的抗生素处方和结局。

Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department.

机构信息

Emergency Department, Hôpital Saint-Louis, Paris, France.

Emergency Department, Hôpital Saint-Joseph, Paris, France.

出版信息

PLoS One. 2020 Feb 28;15(2):e0229828. doi: 10.1371/journal.pone.0229828. eCollection 2020.

DOI:10.1371/journal.pone.0229828
PMID:32109264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7048306/
Abstract

INTRODUCTION

The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic timing and appropriateness on outcomes in patients with febrile neutropenia (FN) and to assess the performance of the MASCC risk-index to risk-stratify such patients in the ED.

METHODS

We prospectively identified patients with FN who presented to our ED and assessed their Multinational Association of Supportive Care in Cancer (MASCC) risk-index. The time to parenteral antibiotic initiation and the appropriateness of the antibiotic regimen according to international guidelines were retrospectively abstracted. The performance of the MASCC risk-index in predicting the absence of complication was assessed with sensitivity, specificity and the area under the receiver operating characteristics curve (AUC). We investigated the effect of the time to antibiotic initiation and the appropriateness of the antibiotic regimen on the outcome (ICU admission or death) by logistic regression analyses.

RESULTS

We included 249 patients. Median age was 60 years and 67.9% had hematological malignancies, 26 (10.4%) were admitted to the ICU and 23 (9.8%) died during hospital stay. Among the 173 patients at low risk according to the MASCC risk-index, 56 (32.4%) presented at least one complication including 11 deaths. The MASCC risk-index had a sensitivity and a specificity of 0.78% and 0.43%, respectively, in predicting the absence of complication and the AUC was 0.67. The time to antibiotic initiation in the ED was not associated with the outcome after adjusting for performance status and shock-index. Conversely, an inadequate ED antibiotic regimen was associated with higher ICU admission or death during hospital stay (OR = 3.50; 95% CI = 1.49 to 8.28).

CONCLUSION

An inadequate ED antibiotic regimen in patients with FN was significantly associated with higher ICU admission or death during hospital stay.

摘要

介绍

在急诊室(ED)减少中性粒细胞减少患者开始使用抗生素的时间的益处存在争议,而关于 ED 中遵循国际指南使用抗生素的影响的研究则很少。我们旨在研究发热性中性粒细胞减少症(FN)患者的抗生素时机和适当性对结局的影响,并评估 MASCC 风险指数在 ED 中对这类患者进行风险分层的效果。

方法

我们前瞻性地确定了就诊于 ED 的 FN 患者,并评估了他们的多国支持癌症治疗协会(MASCC)风险指数。回顾性提取了给予静脉抗生素的时间和根据国际指南的抗生素方案的适当性。通过灵敏度、特异性和接受者操作特征曲线(ROC)下的面积(AUC)评估 MASCC 风险指数预测无并发症的表现。我们通过逻辑回归分析研究了抗生素开始时间和抗生素方案的适当性对结局(入住 ICU 或死亡)的影响。

结果

我们纳入了 249 名患者。中位年龄为 60 岁,67.9%患有血液系统恶性肿瘤,26 名(10.4%)入住 ICU,23 名(9.8%)在住院期间死亡。在 MASCC 风险指数低危的 173 名患者中,有 56 名(32.4%)出现了至少一种并发症,包括 11 例死亡。MASCC 风险指数预测无并发症的灵敏度和特异性分别为 0.78%和 0.43%,AUC 为 0.67。调整表现状态和休克指数后,ED 中抗生素的开始时间与结局无关。相反,ED 抗生素方案不充分与住院期间 ICU 入住或死亡的风险增加相关(OR = 3.50;95%CI = 1.49 至 8.28)。

结论

FN 患者 ED 中抗生素方案不充分与住院期间 ICU 入住或死亡的风险增加显著相关。

相似文献

1
Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department.急诊癌症发热性中性粒细胞减少症患者的抗生素处方和结局。
PLoS One. 2020 Feb 28;15(2):e0229828. doi: 10.1371/journal.pone.0229828. eCollection 2020.
2
Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.急诊科对化疗相关性发热性中性粒细胞减少症的管理:改善护理的机会。
Am J Emerg Med. 2021 Dec;50:5-9. doi: 10.1016/j.ajem.2021.07.008. Epub 2021 Jul 9.
3
A comparison of ED and direct admission care of cancer patients with febrile neutropenia.癌症发热性中性粒细胞减少症患者急诊室就诊与直接入院治疗的比较。
Am J Emerg Med. 2015 Jul;33(7):966-9. doi: 10.1016/j.ajem.2015.04.028. Epub 2015 Apr 23.
4
Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?风险分层工具能否用于安全地让低风险发热性中性粒细胞减少患者从急诊科出院?
J Emerg Med. 2023 Jan;64(1):111-118. doi: 10.1016/j.jemermed.2022.10.010. Epub 2023 Jan 12.
5
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.应用MASCC和CISNE风险分层评分识别急诊科低风险发热性中性粒细胞减少患者。
Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29.
6
Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.全血细胞计数参数在预测因发热性中性粒细胞减少症而就诊于急诊科的癌症患者不良结局中的作用。
Ann Med. 2022 Dec;54(1):599-609. doi: 10.1080/07853890.2022.2031271.
7
Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.MASCC 和 CISNE 评分用于识别低危中性粒细胞减少性发热患者的比较:来自三大洲三个癌症中心急诊部的数据分析。
Support Care Cancer. 2018 May;26(5):1465-1470. doi: 10.1007/s00520-017-3985-0. Epub 2017 Nov 22.
8
[Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].[古斯塔夫-鲁西肿瘤急诊室中癌症发热性中性粒细胞减少症患者的管理方式及其相关成本]
Bull Cancer. 2014 Oct;101(10):925-31. doi: 10.1684/bdc.2014.1958.
9
Time to antibiotics and outcomes in cancer patients with febrile neutropenia.癌症发热性中性粒细胞减少症患者使用抗生素的时机与治疗结果
BMC Health Serv Res. 2014 Apr 10;14:162. doi: 10.1186/1472-6963-14-162.
10
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.使用癌症支持治疗多国协会(MASCC)风险指数管理实体瘤和淋巴瘤中的发热性中性粒细胞减少症:常规临床实践中的可行性和安全性
Support Care Cancer. 2008 May;16(5):485-91. doi: 10.1007/s00520-007-0334-8. Epub 2007 Sep 25.

引用本文的文献

1
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to Action.我们能否降低重症免疫功能低下患者的抗菌药物耐药性(AMR)负担?一项叙述性综述及行动呼吁。
Infect Dis Ther. 2025 Aug 7. doi: 10.1007/s40121-025-01204-4.
2
Clinical Outcome of Febrile Neutropenia and Associated Factors Among Adult Patients with Cancer Treated at Ethiopian Oncology Centers: A Retrospective Observational Study.埃塞俄比亚肿瘤中心接受治疗的成年癌症患者发热性中性粒细胞减少症的临床结局及相关因素:一项回顾性观察研究
Oncol Ther. 2025 Jul 16. doi: 10.1007/s40487-025-00356-0.
3
Clinical prediction models for febrile neutropenia and its outcomes: a systematic review.

本文引用的文献

1
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.多重耐药时代高危中性粒细胞减少血症合并菌血症患者的不适当经验性抗生素治疗。
Clin Infect Dis. 2020 Mar 3;70(6):1068-1074. doi: 10.1093/cid/ciz319.
2
European Society of Emergency Medicine position paper on the 1-hour sepsis bundle of the Surviving Sepsis Campaign: expression of concern.欧洲急诊医学会关于拯救脓毒症运动 1 小时脓毒症捆绑包的立场文件:关注表达。
Eur J Emerg Med. 2019 Aug;26(4):232-233. doi: 10.1097/MEJ.0000000000000603.
3
Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.
发热性中性粒细胞减少症及其预后的临床预测模型:一项系统评价
Support Care Cancer. 2025 Jun 4;33(7):537. doi: 10.1007/s00520-025-09562-y.
4
High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations.血液恶性肿瘤患者在符合国际指南建议的情况下仍存在高比例的抗生素使用不当,且与铜绿假单胞菌菌血症相关。
Microbiol Spectr. 2023 Aug 17;11(4):e0067423. doi: 10.1128/spectrum.00674-23. Epub 2023 Jun 27.
5
Time to antibiotic administration in children with febrile neutropenia: Report from a low middle-income country.发热性中性粒细胞减少症患儿应用抗生素的时间:来自中低收入国家的报告。
Indian J Med Res. 2021 Apr;154(4):615-622. doi: 10.4103/ijmr.IJMR_2483_19.
6
Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.实体瘤患者感染的危险因素、抗生素治疗及其对癌症治疗结果的影响
Life (Basel). 2021 Dec 11;11(12):1387. doi: 10.3390/life11121387.
7
Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance.在抗菌药物耐药时代理解和管理癌症患者的脓毒症
Front Med (Lausanne). 2021 Mar 31;8:636547. doi: 10.3389/fmed.2021.636547. eCollection 2021.
发热性中性粒细胞减少症中抗生素使用时间对住院时间、重症监护病房入住率和死亡率的影响。
Support Care Cancer. 2019 Nov;27(11):4171-4177. doi: 10.1007/s00520-019-04701-8. Epub 2019 Feb 25.
4
Central venous oxygen saturation is not predictive of early complications in cancer patients presenting to the emergency department.中心静脉血氧饱和度不能预测急诊科就诊的癌症患者的早期并发症。
Intern Emerg Med. 2019 Mar;14(2):281-289. doi: 10.1007/s11739-018-1966-z. Epub 2018 Oct 10.
5
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.成人恶性肿瘤患者发热与中性粒细胞减少的门诊管理:美国临床肿瘤学会与感染病学会临床实践指南更新
J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20.
6
Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.美国传染病学会 (IDSA) 立场声明:为何 IDSA 未认可拯救脓毒症运动指南。
Clin Infect Dis. 2018 May 2;66(10):1631-1635. doi: 10.1093/cid/cix997.
7
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症和脓毒性休克管理国际指南:2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.
8
Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia.快速序贯器官衰竭评估评分作为发热性中性粒细胞减少症患者脓毒症、死亡率及重症监护病房入住情况筛查工具的预测性能。
Support Care Cancer. 2017 May;25(5):1557-1562. doi: 10.1007/s00520-016-3567-6. Epub 2017 Jan 6.
9
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.应用MASCC和CISNE风险分层评分识别急诊科低风险发热性中性粒细胞减少患者。
Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29.
10
The Emergency Care of Patients With Cancer: Setting the Research Agenda.癌症患者的急诊护理:设定研究议程
Ann Emerg Med. 2016 Dec;68(6):706-711. doi: 10.1016/j.annemergmed.2016.01.021. Epub 2016 Feb 26.